GBD AEMT USA 2019 DATASET

<br>The GBD 2019 AEMT USA dataset forms a crucial component of the Global Burden of Disease (GBD) study, specifically focusing on the adverse effects of medical treatments (AEMT) within the United States. This comprehensive dataset aggregates and analyzes data from a wide range of sources, including hospital records, insurance claims, and national health surveys, to assess the incidence, outcomes, and healthcare implications associated with AEMT. The dataset utilizes International Classification of Diseases (ICD) codes to meticulously categorize and track health outcomes resulting from medical interventions, enabling researchers to quantify and analyze the burden of AEMT in terms of Disability-Adjusted Life Years (DALYs) lost. This detailed evaluation helps in identifying trends, assessing risk factors, and ultimately guiding healthcare policies to mitigate the adverse effects associated with medical treatments across diverse populations and healthcare settings within the U.S.